AMI, an Indazole Derivative, Improves Parkinson's Disease by Inhibiting Tau Phosphorylation.

Mao, Zhang; Wen-Ting, Zhu; Hai-Tao, Wang; Hui, Yu; Shi-Yi, Lan; Jiang-Ping, Xu; Wen-Ya, Wang

Mao, Zhang; Wen-Ting, Zhu; Hai-Tao, Wang; Hui, Yu; Shi-Yi, Lan; Jiang-Ping, Xu; Wen-Ya, Wang.

Afiliação

Mao Z; School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, China.
Wen-Ting Z; The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Hai-Tao W; School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, China.
Hui Y; School of Basic Medical Science, Southern Medical University, Guangzhou, China.
Shi-Yi L; School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, China.
Jiang-Ping X; School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, China.
Wen-Ya W; School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, China.

Front Mol Neurosci ; 13: 165, 2020.

Article em En | MEDLINE | ID: mdl-33328879

Palavras-chave

6-amino-1-methyl-indazole; MPTP; Parkinson's disease; SH-SY5Y; tau

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Idioma: En Revista: Front Mol Neurosci Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China